Literature DB >> 1171764

Cytosine arabinoside uptake by tumour cells in vitro.

J H Mulder, K R Harrap.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171764     DOI: 10.1016/0014-2964(75)90066-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  2'-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside. Absence of protection of bone marrow lymphocytes.

Authors:  V M Buchman; N I Belyanchikova; D M Mkheidze; T A Litovchenko; M R Lichinitser; M F Barkhotkina; G J Svet-Moldavsky
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.

Authors:  Yu Xu; Cuiming Cao; Xiuchun Gong; LiJun Rong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Nucleoside transport in mammalian cell membranes. III. Kinetic and chemical modification studies of cytosine-arabinoside and uridine transport in hamster cells in culture.

Authors:  O Heichal; O Bibi; J Katz; Z I Cabantchik
Journal:  J Membr Biol       Date:  1978-03-10       Impact factor: 1.843

5.  Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.

Authors:  J C White; J P Rathmell; R L Capizzi
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.

Authors:  V J Richardson; G A Curt; B E Ryman
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.